The Magelia® for post-hematopoietic stem cell transplantation chimerism assessment

Pairing CareDx AlloSeq HCT application with Inorevia’s Magelia omics platform makes your workflow seamless for high quality chimerism studies.

Next-generation sequencing has revolutionized the quantification of chimerism.

The Magelia®’s unique core technologies bring unparalleled sensitivity through reaction optimization, for highly efficient, full automation of diverse workflows, even on challenging, low input samples. The purpose of our evaluation was to compare the results obtained from a pool of patient samples treated with the Magelia® platform with those obtained from a manual purification.

This very promising work in collaboration with EFS PACA was showcased at the 36th European Immunogenetics and Histocompatibility Conference, and the poster is available here .
Made on